EPISODE · Apr 14, 2026 · 5 MIN
The UroOnc Minute: LITESPARK-022 and Adjuvant Therapy in ccRCC, with Wesley Yip, MD
from Urology Times Podcasts · host Urology Times
In this episode of the UroOnc Minute, Wesley Yip, MD, joins host Adam B. Weiner, MD, to discuss key takeaways from the LITESPARK-022 trial, exploring the role for adjuvant pembrolizumab plus belzutifan in patients with clear cell renal cell carcinoma.
Embed this episode
NOW PLAYING
The UroOnc Minute: LITESPARK-022 and Adjuvant Therapy in ccRCC, with Wesley Yip, MD
0:00
5:07
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Urology Times Podcasts?
This episode is 5 minutes long.
When was this Urology Times Podcasts episode published?
This episode was published on April 14, 2026.
Can I download this Urology Times Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!